The Clinical Utility of Precision-Guided Dosing for Adalimumab Therapy Optimization in Inflammatory...
The Clinical Utility of Precision-Guided Dosing for Adalimumab Therapy Optimization in Inflammatory Bowel Disease: A Clinical Experience Program
About this item
Full title
Author / Creator
Hanauer, Stephen B. , Torres, Esther A. , Aragon-Han, Patricia , Chapman, Jonathon C. , Swaminath, Arun C. , Arai, Ronen , Butnariu, Mandalina , Lee, Thomas C. , Rabizadeh, Shervin , Check, Morgan , Barrett, Terrence A. , Hashash, Jana G. , Meister, Thomas , Yen, Eugene F. , Kinnucan, Jami , Stein, Daniel J. , Ziring, David , Shaposhnikov, Rimma , Sinh, Preetika , Qazi, Taha M. , Yarur, Andres J. , Monzur, Farah , Dervieux, Thierry and Abraham, Bincy P.
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Background/Objectives: This study aimed to establish the clinical utility of a therapeutic drug monitoring (TDM)-supported, model-informed precision dosing (MIPD) approach (precision-guided dosing [PGD]) by assessing the impact of pharmacokinetic (clearance [CL]) and clinical laboratory parameters on adalimumab (ADA) dosage adjustments during maint...
Alternative Titles
Full title
The Clinical Utility of Precision-Guided Dosing for Adalimumab Therapy Optimization in Inflammatory Bowel Disease: A Clinical Experience Program
Authors, Artists and Contributors
Author / Creator
Torres, Esther A.
Aragon-Han, Patricia
Chapman, Jonathon C.
Swaminath, Arun C.
Arai, Ronen
Butnariu, Mandalina
Lee, Thomas C.
Rabizadeh, Shervin
Check, Morgan
Barrett, Terrence A.
Hashash, Jana G.
Meister, Thomas
Yen, Eugene F.
Kinnucan, Jami
Stein, Daniel J.
Ziring, David
Shaposhnikov, Rimma
Sinh, Preetika
Qazi, Taha M.
Yarur, Andres J.
Monzur, Farah
Dervieux, Thierry
Abraham, Bincy P.
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_edfe11c1b28946cca3afa1ddc9559e90
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_edfe11c1b28946cca3afa1ddc9559e90
Other Identifiers
ISSN
1999-4923
E-ISSN
1999-4923
DOI
10.3390/pharmaceutics17040428
